Ballard Maturational Assessment
New Ballard Score (Ballard 1991): 6 neuromuscular and 6 physical maturity signs; the total converts to an estimated gestational age of 20–44 weeks.
Score interpretation
Estimated gestational age below 30 weeks (NBS total ≤ 14)
→ Level 3 NICU; surfactant therapy; respiratory support; thermoregulation; parenteral nutrition; indomethacin/ibuprofen for PDA; infection prevention; neuroprotective measures (magnesium, avoid hypoxia); family-centred care; neurodevelopmental follow-up
Estimated gestational age 30 to 36+6 weeks (NBS total 15–32)
→ NICU/SCN care; respiratory monitoring; thermoregulation incubator; establish feeds (NG if unable to suck); caffeine for apnoea of prematurity; vitamin D and iron supplementation; jaundice monitoring; breastfeeding support; ophthalmology for ROP screening if <32 weeks
Estimated gestational age 37 to 41+6 weeks (NBS total 33–44)
→ Routine newborn care; ensure adequate feeding; bilirubin monitoring; newborn examination; vitamin K prophylaxis; hearing screen; metabolic screen; promote skin-to-skin; arrange GP/midwife follow-up within 5 days of discharge
Estimated gestational age 42 weeks or more (NBS total ≥ 45)
→ Routine newborn care; compare with antenatal dating; observe feeding, temperature and glucose
Interpretation bands for the Ballard Score. Apply clinical judgement and local guidance.
References
- Ballard JL et al. New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991;119(3):417–423.
Related
Curated clinical cross-links plus same-class fallbacks.
- Rozanolixizumab · Neonatal Fc receptor (FcRn) antagonist
- Efgartigimod alfa · Neonatal Fc receptor (FcRn) blocker
- Metformin (Gestational Diabetes / PCOS) · Biguanide — Gestational Diabetes / PCOS
- Caffeine Citrate · Methylxanthine (Apnoea of Prematurity)
- Phenobarbital (Paediatric Epilepsy — Beyond Neonatal) · Barbiturate Anticonvulsant
- Gentamicin (Paediatric) · Aminoglycoside — Neonatal Sepsis / Gram-Negative Infections in Children
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.